Precise Treatment System of Biliary Malignancies Based on Special Disease Database

• Conditions: Gall Bladder Carcinoma; Cholangiocarcinoma; Biliary System Disorder

• Registration Number: NCT03499782
• Lead Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Brief Summary

Malignant tumors of biliary system lack standard treatment and precise prognosis assessment methods. This study including 12 hospitals, collecting clinical and follow-up data of patients with biliary malignant tumors including cholangiocarcinoma and gallbladder carcinoma in recent 10 years, aim to build a special disease database, then use Bayesian networks and importance theory to establish a mathematical model to assess treatment strategies and prognosis accurately. At the same time, data on biliary malignant tumors newly treated by multicenters from 2018 to 2020 will be included to validate, adjust and refine the models to guide clinical individualized precise treatment.

Detailed Description

Not available

Study Timeline

• Status Verified: 2018-04
• Study First Submitted: 2018-04-08
• Study First Submitted QC: 2018-04-13
• Last Update Submitted: 2018-04-13
• Study First Posted: 2018-04-17
• Last Update Posted: 2018-04-17
• Study Start: 2018-05-25
• Primary Completion: 2021-08-31
• Study Completion: 2021-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

Not provided

Exclusion Criteria

• Non-primary gallbladder or cholangiocarcinoma
• With distant metastasis (M1 phase)
• Incomplete follow-up data
• Died within 30 days after surgery.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Death from biliary tract carcinoma	Every three months, up to five years	Death from cholangiocarcinoma or gallbladder carcinoma

Trial Locations

Locations (1)

Zhaohui Tang; 🇨🇳 Shanghai, Shanghai, China